BL-214

N/A

Report date: 2024/11/18 15:23:29
NME

Base Information

Drug NameBL-214
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsHypertensionErectile DysfunctionProstatic Hyperplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiolab Sanus Farmaceutica Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolab Sanus Farmaceutica Llc
Active IndicationsN/A
Inactive IndicationsHypertensionErectile DysfunctionProstatic Hyperplasia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A